MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations

MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 5 citations, 2025 year and hybrid oa status.